Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Title
Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 16, Issue 6, Pages 1938-1949
Publisher
American Association for Cancer Research (AACR)
Online
2010-03-10
DOI
10.1158/1078-0432.ccr-08-3328

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation